![Mark B. Roth](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark B. Roth
Oprichter bij Faraday Pharmaceuticals, Inc.
Actieve functies van Mark B. Roth
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Faraday Pharmaceuticals, Inc.
![]() Faraday Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Faraday Pharmaceuticals, Inc. engages in the research and development of elemental reducing agents (ERAs). Its therapeutic agents have potential applications for treatment of critical care illnesses. The company was founded by Mark B. Roth and Christopher Toombs in 2014 and is headquartered in Seattle, WA. | Directeur/Bestuurslid | 01-01-2014 | - |
Oprichter | 01-01-2014 | - | |
President | 01-01-2014 | - | |
Faraday Pharmaceuticals, Inc. (Washington)
![]() Faraday Pharmaceuticals, Inc. (Washington) Drugstore ChainsRetail Trade Faraday Pharmaceuticals, Inc. develops small molecule drugs for the treatment of central nervous system disorders and cardiovascular diseases. The company was founded in 2001 and is headquartered in Seattle, WA. | Directeur/Bestuurslid | - | - |
Loopbaan van Mark B. Roth
Statistieken
Internationaal
Verenigde Staten | 3 |
Operationeel
Director/Board Member | 2 |
Founder | 1 |
President | 1 |
Sectoraal
Health Technology | 2 |
Retail Trade | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Faraday Pharmaceuticals, Inc.
![]() Faraday Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Faraday Pharmaceuticals, Inc. engages in the research and development of elemental reducing agents (ERAs). Its therapeutic agents have potential applications for treatment of critical care illnesses. The company was founded by Mark B. Roth and Christopher Toombs in 2014 and is headquartered in Seattle, WA. | Health Technology |
Faraday Pharmaceuticals, Inc. (Washington)
![]() Faraday Pharmaceuticals, Inc. (Washington) Drugstore ChainsRetail Trade Faraday Pharmaceuticals, Inc. develops small molecule drugs for the treatment of central nervous system disorders and cardiovascular diseases. The company was founded in 2001 and is headquartered in Seattle, WA. | Retail Trade |
- Beurs
- Insiders
- Mark B. Roth
- Ervaring